Current State of Preeclampsia Mouse Models: Approaches, Relevance, and Standardization

Preeclampsia (PE) is a multisystemic, pregnancy-specific disorder and a leading cause of maternal and fetal death. PE is also associated with an increased risk for chronic morbidities later in life for mother and offspring. Abnormal placentation or placental function has been well-established as cen...

Full description

Bibliographic Details
Main Authors: Christopher A. Waker, Melissa R. Kaufman, Thomas L. Brown
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2021.681632/full
id doaj-3752c3ee4caa4d398957af89c342e97d
record_format Article
spelling doaj-3752c3ee4caa4d398957af89c342e97d2021-07-02T14:36:28ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2021-07-011210.3389/fphys.2021.681632681632Current State of Preeclampsia Mouse Models: Approaches, Relevance, and StandardizationChristopher A. WakerMelissa R. KaufmanThomas L. BrownPreeclampsia (PE) is a multisystemic, pregnancy-specific disorder and a leading cause of maternal and fetal death. PE is also associated with an increased risk for chronic morbidities later in life for mother and offspring. Abnormal placentation or placental function has been well-established as central to the genesis of PE; yet much remains to be determined about the factors involved in the development of this condition. Despite decades of investigation and many clinical trials, the only definitive treatment is parturition. To better understand the condition and identify potential targets preclinically, many approaches to simulate PE in mice have been developed and include mixed mouse strain crosses, genetic overexpression and knockout, exogenous agent administration, surgical manipulation, systemic adenoviral infection, and trophoblast-specific gene transfer. These models have been useful to investigate how biological perturbations identified in human PE are involved in the generation of PE-like symptoms and have improved the understanding of the molecular mechanisms underpinning the human condition. However, these approaches were characterized by a wide variety of physiological endpoints, which can make it difficult to compare effects across models and many of these approaches have aspects that lack physiological relevance to this human disorder and may interfere with therapeutic development. This report provides a comprehensive review of mouse models that exhibit PE-like symptoms and a proposed standardization of physiological characteristics for analysis in murine models of PE.https://www.frontiersin.org/articles/10.3389/fphys.2021.681632/fullplacentapreeclampsiapregnancymousemodelshypertension
collection DOAJ
language English
format Article
sources DOAJ
author Christopher A. Waker
Melissa R. Kaufman
Thomas L. Brown
spellingShingle Christopher A. Waker
Melissa R. Kaufman
Thomas L. Brown
Current State of Preeclampsia Mouse Models: Approaches, Relevance, and Standardization
Frontiers in Physiology
placenta
preeclampsia
pregnancy
mouse
models
hypertension
author_facet Christopher A. Waker
Melissa R. Kaufman
Thomas L. Brown
author_sort Christopher A. Waker
title Current State of Preeclampsia Mouse Models: Approaches, Relevance, and Standardization
title_short Current State of Preeclampsia Mouse Models: Approaches, Relevance, and Standardization
title_full Current State of Preeclampsia Mouse Models: Approaches, Relevance, and Standardization
title_fullStr Current State of Preeclampsia Mouse Models: Approaches, Relevance, and Standardization
title_full_unstemmed Current State of Preeclampsia Mouse Models: Approaches, Relevance, and Standardization
title_sort current state of preeclampsia mouse models: approaches, relevance, and standardization
publisher Frontiers Media S.A.
series Frontiers in Physiology
issn 1664-042X
publishDate 2021-07-01
description Preeclampsia (PE) is a multisystemic, pregnancy-specific disorder and a leading cause of maternal and fetal death. PE is also associated with an increased risk for chronic morbidities later in life for mother and offspring. Abnormal placentation or placental function has been well-established as central to the genesis of PE; yet much remains to be determined about the factors involved in the development of this condition. Despite decades of investigation and many clinical trials, the only definitive treatment is parturition. To better understand the condition and identify potential targets preclinically, many approaches to simulate PE in mice have been developed and include mixed mouse strain crosses, genetic overexpression and knockout, exogenous agent administration, surgical manipulation, systemic adenoviral infection, and trophoblast-specific gene transfer. These models have been useful to investigate how biological perturbations identified in human PE are involved in the generation of PE-like symptoms and have improved the understanding of the molecular mechanisms underpinning the human condition. However, these approaches were characterized by a wide variety of physiological endpoints, which can make it difficult to compare effects across models and many of these approaches have aspects that lack physiological relevance to this human disorder and may interfere with therapeutic development. This report provides a comprehensive review of mouse models that exhibit PE-like symptoms and a proposed standardization of physiological characteristics for analysis in murine models of PE.
topic placenta
preeclampsia
pregnancy
mouse
models
hypertension
url https://www.frontiersin.org/articles/10.3389/fphys.2021.681632/full
work_keys_str_mv AT christopherawaker currentstateofpreeclampsiamousemodelsapproachesrelevanceandstandardization
AT melissarkaufman currentstateofpreeclampsiamousemodelsapproachesrelevanceandstandardization
AT thomaslbrown currentstateofpreeclampsiamousemodelsapproachesrelevanceandstandardization
_version_ 1721327909991350272